Abstract:Background/Aims: Since the first case of novel H7N9 infection was reported, China has experienced five epidemics of H7N9. During the fifth wave, a highly pathogenic H7N9 strain emerged. In order to assess whether the H7N9 vaccine based on A/Zhejiang/DTID-ZJU01/ 2013(H7N9) was effective in protecting against highly pathogenic H7N9, we conducted this study. Methods: Groups of mice were immunized twice by intraperitoneal injection with 500 mu l of either split vaccine alone or MF59- adjuvanted vaccine. Serum was collected 2 weeks after the second vaccine booster. The hemagglutinin inhibition test was conducted on vaccine seed and highly pathogenic H7N9 to evaluate the neutralization of highly pathogenic H7N9. We also immunized mice and challenged them with highly pathogenic H7N9. Mice were observed for illness, weight loss, and death at 1 week and 2 weeks post- infection. Then, the mice were sacrificed and lungs were removed. Antibody responses were assessed and pathological changes in the lung tissue were evaluated. Results: The ability of serum to neutralize highly pathogenic H7N9 was reduced. In mice, highly pathogenic H7N9 was more virulent than A/Zhejiang/DTID- ZJU01/2013(H7N9). After challenge with highly pathogenic H7N9, all mice died while mice challenged with A/Zhejiang/DTID- ZJU01/2013(H7N9) all recovered. The A/ZJU01/PR8/2013 split H7N9 avian influenza vaccine was able to protect against infection with highly pathogenic H7N9 in mice, with or without MF59. Moreover, H7N9 vaccine adjuvanted with MF59 produced high antibody levels, which lead to better protection. Conclusions: The A/ZJU01/PR8/2013 split H7N9 avian influenza vaccine based on A/Zhejiang/DTID- ZJU01/2013( H7N9) is effective in protecting against highly pathogenic H7N9. H7N9 vaccine adjuvanted with MF59 offers better protection against infection with highly pathogenic H7N9. In order to make the H7N9 vaccine applicable to humans, further clinical trials are required to evaluate MF59 adjuvanted vaccine. Meanwhile, the vaccine strain should be updated based on the highly pathogenic H7N9 gene sequence. (C) 2018 The Author(s) Published by S. Karger AG, Basel

Studies on the Biological Characteristics of H7N3 Subtype of Avian Influenza Virus

Isolation and Characterization of A Novel H10n2 Avian Influenza Virus from A Domestic Duck in Eastern China

Characterization of a Novel Highly Pathogenic H5N2 Avian Influenza Virus Isolated from a Duck in Eastern China

Characterization of the Pathogenesis of H10N3, H10N7, and H10N8 Subtype Avian Influenza Viruses Circulating in Ducks.

Molecular Characterization and Phylogenetic Analysis of H3 Subtype Avian Influenza Viruses Isolated from Domestic Ducks in Zhejiang Province in China.

Virulence of three European highly pathogenic H7N1 and H7N7 avian influenza viruses in Pekin and Muscovy ducks

Molecular Characterization of H10 Subtype Avian Influenza Viruses Isolated from Poultry in Eastern China

The Protective Effects of the A/ZJU01/ PR8/2013 Split H7N9 Avian Influenza Vaccine Against Highly Pathogenic H7N9 in BALB/c Mice.

Genetic Characterization of Natural Reassortant H4 Subtype Avian Influenza Viruses Isolated from Domestic Ducks in Zhejiang Province in China from 2013 to 2014

Sequence and Phylogenetic Analysis of H2N7 Avian Influenza Viruses Isolated from Domestic Ducks in Zhejiang Province, Eastern China, 2013

Isolation and characterization of two novel reassortant H5N6 avian influenza viruses from waterfowl in eastern China

Isolation and Characterization of a Novel H7N8 Avian Influenza Virus from Domestic Ducks in Central China in 2017

Characteristics of Avian Influenza A (H7N9) Virus and Its Pathogenicity in Human Beings

Characterization of Low-Pathogenic H6N6 Avian Influenza Viruses in Central China.

Mouse Models Choosing for the Comparative Study of Different Pathogenic Avian Influenza Viruses

Establishing a Multicolor Flow Cytometry to Characterize Cellular Immune Response in Chickens Following H7N9 Avian Influenza Virus Infection

Novel Pathogenic Characteristics of Highly Pathogenic Avian Influenza Virus H7N9: Viraemia and Extrapulmonary Infection

The Variation of Duck RIG-I-Mediated Innate Immune Response Induced by Different Virulence Avian Influenza Viruses

Isolation and Molecular Characterization of Reassortant H11N3 Subtype Avian Influenza Viruses Isolated from Domestic Ducks in Zhejiang Province in China.

Adaptive Amino Acid Substitutions Enhance the Virulence of an Avian-Origin H6N1 Influenza Virus in Mice

Novel Reassortant H10N7 Avian Influenza Viruses Isolated from Chickens in Eastern China.